MSDC-0160,
146062-49-9,
Mitoglitazone,
MSDC-0160,
CAY10415,
CAY 10415,
MSDC 0160,
5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione,
5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)-benzyl)thiazolidine-2,4-dione,
2,4-THIAZOLIDINEDIONE, 5-[[4-[2-(5-ETHYL-2-PYRIDINYL)-2-OXOETHOXY]PHENYL]METHYL]-,
SCHEMBL622605,
US9562012, mitoglitazone,
CHEMBL146624,
MSDC0160,
SCHEMBL18538169,
CHEBI:94409,
CTK4C4798,
IRNJSRAGRIZIHD-UHFFFAOYSA-N,
Mitoglitazone, >=98% (HPLC),
BDBM228129,
BCP16099,
EX-A1483,
2172AH,
CAY-10415,
MFCD00916084,
s7453,
AKOS026750561,
CS-6405,
DB11721,
SB17325,
MSDC-0160(CAY10415),
AK471596,
QC-11656,
HY-100550,
RT-011931,
U-91325,
J-008189,
BRD-A61858259-001-01-0,
5-[4-[2-(5-ethyl-2-pyridyl)-2-oxoethoxy]benzyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
5-{4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]benzyl}-1,3-thiazolidine-2,4-dione,
Mitoglitazone (TN),
UNII-29I7RP18RG,
D00SWQ,
29I7RP18RG,
C19H18N2O4S,
CID10429242,
C580959,
5-[[4-[2-(5-ethylpyridin-2-yl)-2-oxo-ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,